Apis Capital Advisors, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Apis Capital Advisors, LLC

  • $108 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$64.07 - $91.75 $896,979 - $1.28 Million
-14,000 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$65.07 - $98.24 $260,279 - $392,960
-4,000 Reduced 22.22%
14,000 $1.2 Million
Q3 2019

Nov 14, 2019
BUY
$37.38 - $49.47 $672,840 - $890,460
18,000 New
18,000 $751,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
785K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Apis Capital Advisors, LLC Portfolio

Follow Apis Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apis Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apis Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email